Leishmaniasis is a neglected infectious disease caused by protozoan parasites from
Leishmania genus species, affecting millions of people, in several countries. The current …

Leishmaniasis and trypanosomiasis (Chagas disease and African sleeping sickness) are
potentially lethal, tropical neglected diseases. These vector-borne protozoal diseases …

Optimisation of drug carrier systems and drug delivery strategies that take into account the
peculiarities of individual infectious agents and diseases are key elements of modern drug …

Leishmaniasis is a neglected tropical disease caused by a protozoan parasite of the genus
Leishmania. Visceral leishmaniasis is the most severe type and is transmitted by the …

Background: The current chemotherapy agents against various forms of leishmaniasis have
some problems and side effects, including high toxicity, high cost, and the emergence of …

The current work focuses on the study of polymeric, biodegradable nanoparticles (NPs) for
the encapsulation of doxorubicin and mitomycin C (anti-leishmanial drugs), and their …

Purpose Leishmaniasis is a disease caused by different Leishmania spp., which are
transmitted to humans by a bite of infected female sand flies. Cutaneous leishmaniasis (CL …

Visceral leishmaniasis is a life-threatening disease that affects nearly a million people every
year. The emergence of Leishmania strains resistant to existing drugs complicates its …

In this study, 2-hydroxypropyl-β-cyclodextrin (HPβCD) grafted solid lipid nanoparticle (SLN)-
based bioconjugate was synthesized and used for administering a combination of melatonin …

Bisnaphthalimidopropyl (BNIP) derivatives have recently been shown to have potential as
antileishmanial agents. However, these compounds have some drawbacks, including their …